Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,241Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11VERTEX PHARMS

02 385VERTEX PHARMS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR

US Patent Number : 8324242

Drug Substance Claim :

Drug Product Claim :

Application Number : 203188

Patent Use Code : U-1311

Delist Requested :

Patent Use Description : METHOD OF TREATING CYS...

Patent Expiration Date : 2027-08-05

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR; LUMACAFTOR

US Patent Number : 8846718

Drug Substance Claim :

Drug Product Claim :

Application Number : 206038

Patent Use Code : U-1717

Delist Requested :

Patent Use Description : METHOD OF TREATING CYS...

Patent Expiration Date : 2029-07-02

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR; LUMACAFTOR

US Patent Number : 8324242

Drug Substance Claim :

Drug Product Claim :

Application Number : 206038

Patent Use Code : U-1911

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-05

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR; LUMACAFTOR

US Patent Number : 8716338

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206038

Patent Use Code : U-1910

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-09-20

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR

US Patent Number : 9670163

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203188

Patent Use Code : U-1311

Delist Requested :

Patent Use Description : METHOD OF TREATING CYS...

Patent Expiration Date : 2026-12-28

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR; LUMACAFTOR

US Patent Number : 7973038

Drug Substance Claim :

Drug Product Claim :

Application Number : 206038

Patent Use Code : U-1973

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-08

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR; LUMACAFTOR

US Patent Number : 7973038

Drug Substance Claim :

Drug Product Claim :

Application Number : 206038

Patent Use Code : U-1973

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-08

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR; LUMACAFTOR

US Patent Number : 9192606

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206038

Patent Use Code : U-1912

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-29

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR; LUMACAFTOR

US Patent Number : 8716338

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206038

Patent Use Code : U-1718

Delist Requested :

Patent Use Description : METHOD OF TREATING CYS...

Patent Expiration Date : 2030-09-20

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVACAFTOR; LUMACAFTOR

US Patent Number : 8324242

Drug Substance Claim :

Drug Product Claim :

Application Number : 206038

Patent Use Code : U-1311

Delist Requested :

Patent Use Description : METHOD OF TREATING CYS...

Patent Expiration Date : 2027-08-05

blank